Orexigen Therapeutics, Inc. (NASDAQ:OREX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity.

Results 1 - 20 of 36 : 1 2 Next »

Recs

0
Member Avatar NuclearSteve (72.70) Submitted: 12/18/2014 10:22:20 AM : Outperform Start Price: $6.39 OREX Score: -1.57

Looks like (right now) it could be the winner of the "Medicate America's Hand to Mouth Disease". Prescriptions trajectory (courtesy of Spenser on Seeking Alpha) are better than that of ARNA and VVUS. I jumping in before the European Union's decision tomorrow to ok the drug. So, far ARNA and VVUS have had their drugs rejected by our European friends. However, I think Contrave has a decent shot at approval and, if that happens, OREX gains a pretty huge advantage.

Recs

0
Member Avatar s2dbaker (83.74) Submitted: 11/11/2014 12:05:12 AM : Outperform Start Price: $5.05 OREX Score: +24.14

This stock will never go down again!

Recs

0
Member Avatar genedom (98.11) Submitted: 6/22/2014 12:37:48 PM : Outperform Start Price: $6.07 OREX Score: -1.10

Undervalued stock with huge momentum.

Recs

0
Member Avatar TerryFool (55.34) Submitted: 4/4/2014 3:50:32 PM : Outperform Start Price: $5.78 OREX Score: -1.18

BUY PULLBACK

Recs

0
Member Avatar TMFBiologyFool (96.90) Submitted: 1/28/2014 11:30:26 AM : Outperform Start Price: $6.80 OREX Score: -22.55

Takeda appears willing to do what it takes to make Contrave successful.

Recs

0
Member Avatar rknapton (< 20) Submitted: 8/22/2013 4:48:21 PM : Underperform Start Price: $6.96 OREX Score: +33.05

Short. Trading at 200x sales. Massive losses and selling tons of stock.

Recs

0
Member Avatar solanZRaider (< 20) Submitted: 3/4/2013 4:19:11 PM : Outperform Start Price: $6.55 OREX Score: -37.76

HealthcareGuy

Recs

0
Member Avatar 78taxs (< 20) Submitted: 8/4/2012 5:53:36 PM : Outperform Start Price: $4.61 OREX Score: -10.64

there doing well

Recs

0
Member Avatar phatchips767 (< 20) Submitted: 6/27/2012 8:46:53 PM : Outperform Start Price: $5.53 OREX Score: -41.65

porto. likedded it.

Recs

0
Member Avatar Flipdaflop (< 20) Submitted: 6/8/2012 4:17:24 PM : Outperform Start Price: $3.42 OREX Score: +31.16

Give it a shoot what do you have to loose money lol let get it

Recs

1
Member Avatar siri22 (< 20) Submitted: 12/16/2011 3:16:43 PM : Outperform Start Price: $1.58 OREX Score: +230.80

A two year wait for an gaurnteed 10 bagger, damn smartphone

Recs

0
Member Avatar Lcrazylegs84 (< 20) Submitted: 9/21/2011 9:02:03 PM : Outperform Start Price: $2.13 OREX Score: +114.83

Its ready to make me some money!!!

Recs

0
Member Avatar modestus1 (< 20) Submitted: 6/3/2011 12:52:58 AM : Outperform Start Price: $2.14 OREX Score: +137.12

Friday's announcement

Recs

0
Member Avatar jsgant13 (99.18) Submitted: 2/8/2011 9:39:51 PM : Outperform Start Price: $3.50 OREX Score: +24.65

sac

Recs

1
Member Avatar telcomac99 (83.66) Submitted: 2/7/2011 9:41:09 AM : Outperform Start Price: $3.99 OREX Score: +1.94

The drug still has a chance... after big drop last week, seems like the risk/reward ratio is very favorable, especially for the CAPS portfolio. Let's see if I can't pick up a quick couple points on the rebound and lock in a winner...

Recs

0
Member Avatar yik6402 (< 20) Submitted: 1/15/2011 11:44:34 PM : Outperform Start Price: $9.55 OREX Score: -93.59

I believe this "contrave" will be extremely critical coming Jan 31 when FDA approves or disapprove. The Board of Review already voted 13-7 most of the time the FDA approves on the recommendations. The other two Arena and VVUS pose no threat here but VVUS already gone over seas to seek aprroval but if Contrave Approves most likely they will try to go ove to Europe to Broaden sales and groth to the company. All in all its in the Bag!

Recs

0
Member Avatar albiedog (< 20) Submitted: 12/24/2010 4:55:43 PM : Outperform Start Price: $8.00 OREX Score: -85.92

Just got recomendation for approval from FDA advisory committee. Expected to get FDA approval in Jan.

Recs

0
Member Avatar chakkar1 (< 20) Submitted: 12/14/2010 9:45:08 AM : Outperform Start Price: $8.88 OREX Score: -94.32

Strong possibility of Contrave being approved by the FDA (31-Jan-2011 meeting) after early Dec-2010 recommendation from FDA advisory panel. Contrave is made up of two FDA-approved drugs with long histories and data to back up safety claims.

Recs

0
Member Avatar jrlpurnell (< 20) Submitted: 12/9/2010 3:29:21 PM : Outperform Start Price: $8.85 OREX Score: -95.59

Two drugs that people are already taking that may make you loose weight + an overweight population = profit

Recs

0
Member Avatar Longshot520 (49.51) Submitted: 12/9/2010 11:50:55 AM : Outperform Start Price: $9.02 OREX Score: -97.26

$1 billion dollar well with no buckets in it...until VVUS and OREX.

Results 1 - 20 of 36 : 1 2 Next »

Featured Broker Partners


Advertisement